Let’s dive into the research, and maybe by the end you will be interested in trying this technique for healing bloating, constipation and IBS yourself. 😇
Irritable bowel syndrome (IBS) is one of the most prevalent functional gastrointestinal disorders worldwide, affecting approximately 7–21% of the population, with a higher prevalence among women (Chey et al., 2015). IBS is characterized by chronic abdominal pain, bloating, and altered bowel habits in the absence of identifiable structural pathology. Despite being labeled a “functional” disorder, IBS imposes a substantial burden on patients and healthcare systems, contributing to reduced quality of life, increased healthcare utilization, work absenteeism, and psychological distress.
Conventional treatments for IBS, including dietary modification, pharmacologic agents, and antibiotics often yield modest or inconsistent results. This has prompted increased interest in therapies that target the gut-brain axis, a bidirectional communication system involving neural, hormonal, and immune pathways. IBS is now widely understood to involve visceral hypersensitivity, altered central pain processing, and dysregulated autonomic nervous system activity. In fact, IBS is now being recognized as a ‘disorder of gut-brain interaction’. As such, treatments that modulate cognitive, emotional, and physiological responses to gut stimuli may address core mechanisms of the disorder rather than peripheral symptoms alone.
Gut-directed hypnotherapy (GDH) is a structured psychological intervention that uses hypnotic suggestion to influence gastrointestinal function, visceral sensitivity, and autonomic regulation. Unlike general relaxation techniques, GDH specifically targets gut–brain signaling and has been proposed as a mechanism-based treatment for IBS. Studies have shown significant improvements, dating back to 1999 and 2002, so this research is not brand new, yet this knowledge is still not very widespread (Vidakovic-Vukic M. 1999 , Gonsalkorale et al., 2002). The most recent research is well summarized in this 2025 meta-analysis, which summarized sixteen randomized controlled studies, found that 40% to 81% of subjects experienced improvement of abdominal symptoms, with additional benefits of reduced anxiety and depression (Almogbel et al., 2025). A common treatment for IBS is the low-FODMAP diet. Interestingly, a 2016 study found that effects of gut-directed hypnotherapy are similar to those of the low FODMAP diet for relief of gastrointestinal symptoms (Peters et. al., 2016). Additionally, they found that hypnotherapy had superior efficacy to the diet on psychological indices such as anxiety and depression. I’m going to explore the results of three primary research studies investigating the efficacy of hypnotherapy for IBS to determine whether hypnotherapy should be recommended as a treatment option.
1) First study: Gonsalkorale et al. (2003) – Long-Term Benefits of Hypnotherapy for IBS
Gonsalkorale et al. (2003) conducted a prospective cohort study evaluating the long-term outcomes of gut-directed hypnotherapy in patients with refractory IBS. The study included 204 patients treated at a tertiary referral center who had failed conventional medical management. Participants completed validated questionnaires assessing IBS symptom severity, quality of life, anxiety, and depression at baseline, immediately following treatment, and during long-term follow-up extending up to six years.
Approximately 71% of patients demonstrated a clinically meaningful response to hypnotherapy in the short term. Among these responders, 81% maintained symptom improvements during long-term follow-up, with sustained reductions in abdominal pain, bloating, and bowel dysfunction (p < .001). Improvements in psychological well-being and quality of life were also maintained, and many patients reported reduced medication use and healthcare utilization over time. While there was some improvement in many areas (bowel habit dissatisfaction and life interference) in the non-responder group immediately after hypnotherapy treatment, it was not as strong of an improvement compared to the responder group, and it was significant at follow up only for mood. Overall, this makes me think that there is still potential for this treatment to help these ‘non-responders’, as they may benefit from more frequent or longer duration of HT support or education as to why this method helps, in order to see the same benefits. As we will see in later studies, psychoeducation alone helps people improve symptoms. This is incredible! In working with clients and educating them on these topics myself, I have seen this to be true.
Research Quality
The major strength of this study lies in its large sample size and very long follow-up period, which provides rare insight into the durability of hypnotherapy’s effects. However, the absence of a control group and randomization limits causal inference. The study population consisted largely of highly motivated patients referred to a specialist center, raising the possibility of selection and expectancy bias. Despite these limitations, the consistency and longevity of symptom improvement suggest clinically meaningful benefits that merit further research with controlled trials.
2) Second study: Anderson et al. (2025) – Digitally Delivered Gut-Directed Hypnotherapy
Anderson et al. (2025) conducted a randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy program with an active control intervention in adults with IBS. Participants were randomized to either a structured digital hypnotherapy program or a digital educational program that provided IBS-related information without hypnotic content. Outcomes were assessed using validated measures of IBS symptom severity and quality of life at baseline and post-intervention.
This study was designed to address two key limitations of earlier hypnotherapy research: limited accessibility and insufficient control for nonspecific treatment effects. By using a digital platform and an active control rather than a wait-list, the authors aimed to isolate the specific effects of hypnotherapy.
Participants receiving digital hypnotherapy experienced significantly greater reductions in global IBS symptom severity compared to the active control group. Improvements were particularly evident in abdominal pain and bloating. A higher proportion of patients in the hypnotherapy group achieved clinically meaningful symptom improvement (p<0.002), and quality-of-life scores improved to a greater extent than in the control group. While a surprising 63% of people in the Active Control group had improvements, 81% in the hypnotherapy group had symptom improvements, which is significantly higher than the controls. Importantly, treatment efficacy was comparable to outcomes reported in in-person hypnotherapy trials, showing that the app Nerva can be a good replacement for in-person hypnotherapy. They used several surveys to assess symptom improvement, similar to other studies, they used the IBS Symptom Severity Scale (IBS-SSS), quality of life, and psychological symptoms (Depression Anxiety and Stress Scale-21) at regular intervals during the program. The length of study was only 6 months but this is still very promising in terms of duration of benefits. I have used Nerva myself and recommend it to clients.
Research Quality
This study demonstrates strong methodological rigor. The randomized controlled design and use of an active control strengthen its validity by reducing placebo and expectancy effects, and suggesting causality of intervention and improved symptom response. There were 240 participants which lends itself to strong statistical power. The digital format standardizes intervention delivery and enhances reproducibility while addressing barriers to access. Some limitations include reliance on self-reported outcomes and a relatively short follow-up period, which limits conclusions regarding long-term durability. Interestingly, 90% of the study participants were female, and the median age was 38. Perhaps the results may be most applicable to this demographic group. Overall, this study provides high-quality evidence supporting the efficacy and scalability of gut-directed hypnotherapy for treating IBS.
3) Flik et al. (2019) – The IMAGINE Multicentre Randomized Controlled Trial
The IMAGINE trial (Flik et al., 2019) is a multicenter randomized controlled trial involving 354 patients with IBS recruited from primary and secondary care from 11 different hospitals in the Netherlands. Participants were randomized to individual hypnotherapy, group hypnotherapy, or an educational supportive therapy control. Treatment was delivered over three months, with follow-up assessments at 3, 6, and 12 months. The primary outcome was adequate relief of IBS symptoms.
At three months, 40.8% of patients receiving individual hypnotherapy and 33.2% receiving group hypnotherapy reported adequate symptom relief, compared with 16.7% in the control group. The confidence intervals show some marginal overlap, but still show significant differences between the controls and intervention groups. These were also statistically significant when compared using odds ratios at three and six months post-treament. Improvements were sustained at 12 months, and group hypnotherapy was found to be non-inferior to individual treatment. While the individual therapy group had slightly higher percentage of participants with improvements (41%) compared to the group therapy (33%), this was still within their ‘non-inferiority margin of 15%’. These findings demonstrate both efficacy and feasibility of HT for broader clinical implementation.
Research Quality
This study represents the strongest evidence among the three papers due to its randomized controlled design, large sample size. While participant blinding was not possible, the educational control helps mitigate nonspecific effects. The use of standardized outcome measures and long-term follow-up strengthens reliability. Overall, the IMAGINE trial provides robust evidence for hypnotherapy as an effective IBS treatment. Since patients were referred by both primary and secondary medical centres from 11 different centres, there is not likely to be much selection bias, but it would be important to take a closer look at the data and make sure there are no random effects coming from the referral-centres.
Comparison of all 3 Studies
Across all three studies, gut-directed hypnotherapy consistently improved IBS symptoms, particularly abdominal pain and global symptom burden. The studies differ in design and statistical strength. Gonsalkorale et al. (2003) provide compelling long-term observational data but lack experimental control. Anderson et al. (2025) demonstrate efficacy beyond placebo using a modern, scalable digital format. Flik et al. (2019) offer the most methodologically rigorous evidence through a large multicenter randomized controlled trial. The IMAGINE trial had the largest sample size (354), which makes it the most statistically powerful study. Both the IMAGINE trial and Anderson trial had active control groups that involved education on the gut-brain connection, which I find fascinating and improve the reliability of their findings.
These three studies used similar surveys to assess differences in symptom severity. The Gonsalkorale et al. study used a validated IBS questionnaire, the The Hospital Anxiety and Depression (HAD) Scale as well as a subjective assessment questionnaire. The Anderson et al. study used the IBS Symptom Severity Scale (IBS-SSS), quality of life, and psychological symptoms (Depression Anxiety and Stress Scale-21), which is similar to the previous assessments. The IMAGINE study used a similar version of the IBS questionnaire translated into Dutch. It’s important to use standardized questionnaires to build reliability and comparability of findings across multiple studies.
In terms of reliability, the IMAGINE trial carries the greatest weight due to its sample size, randomization, and control condition. The long-term durability (6 years) observed by Gonsalkorale et al. complements these findings with, while Anderson et al. address accessibility format and standardization, which are key barriers to real-world implementation. Together, these studies form a coherent and convergent evidence base in support of hypnotherapy in treating IBS in individual, group and digital delivery formats.
Conclusion and Clinical Recommendation
The collective evidence supports gut-directed hypnotherapy as an effective treatment for IBS. Randomized controlled trials demonstrate symptom improvement beyond educational and supportive interventions, while long-term observational data suggest long-term benefits. Importantly, digital delivery models indicate that hypnotherapy can be both scalable and accessible in a digital format.
Based on the current evidence, I would recommend gut-directed hypnotherapy to appropriate clients, particularly those with persistent symptoms, heightened visceral sensitivity, anxiety, or stress-related symptom exacerbation. Hypnotherapy offers a low-risk, mechanism-based intervention that aligns with contemporary understanding of IBS as a disorder of gut–brain interaction. While further research is needed to refine patient selection and long-term outcomes, the existing literature supports hypnotherapy as a clinically meaningful and evidence-based option in IBS management. In certain cases, I would recommend HT as a starting point before trying a diet intervention like low-FODMAP to isolate the effects of hypnotherapy before adding in diet and supplement plans, as it will help set a strong nervous system foundation. I feel comfortable recommending it via an app like Nerva, or with an individual practitioner or in a group setting as all are able to give similarly reliable positive results.
After conducting this research review, I decided to record a gut-directed hypnotherapy recording for you to try out, completely free!
Let me know if you try it and how it goes for you!
To your gut healing,
🌈 Heather 🌟
References
Almogbel, E., A Al-Harbi, F., Alamro, A. M., Al-Saif, A. K., Alghamdi, S. M., Alkhalifah, K. A., Alayed, R. S., & Al-Mutairi, T. A. (2025). Efficacy of hypnotherapy in the treatment of irritable bowel syndrome (IBS): a systematic review and meta-analysis. The American journal of clinical hypnosis, 1–15. Advance online publication. https://doi.org/10.1080/00029157.2025.2585911
Anderson, E. J., Peters, S. L., Gibson, P. R., & Halmos, E. P. (2025). Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. The American Journal of Gastroenterology, 120(2), 440–448. https://doi.org/10.14309/ajg.0000000000002921
Chey, W. D., Kurlander, J., & Eswaran, S. (2015). Irritable bowel syndrome: A clinical review. JAMA, 313(9), 949–958.
Flik, C. E., et al. (2019). Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE). The Lancet Gastroenterology & Hepatology.
Gonsalkorale, W. M., Miller, V., Afzal, A., & Whorwell, P. J. (2003). Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut, 52(11), 1623–1629.
Gonsalkorale, W. M., Houghton, L. A., Whorwell, P. J. (2002). Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness, The American Journal of Gastroenterology, 97(4), 954-961, https://doi.org/10.1016/S0002-9270(02)03971-0.
Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics, 44(5), 447–459. https://doi.org/10.1111/apt.13706
Vidakovic-Vukic M. (1999). Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scandinavian journal of gastroenterology. Supplement, 230, 49–51. https://doi.org/10.1080/003655299750025543
Neuro Fit For Life 